This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. The FDA cleared BrainsWay D treatment of Major Depression in patients who failed to respond to one or more anti-depressants in the current episode.
David Feifel is a Professor Emeritus at UCSD Medical Center and a former Director of the Neurospsychiatry and Behavioral Medicine Program at the Center.
He is currently, Director of Kadima Neuropsychiatry Institute in La Jolla, California
Professor Feifel has a Diplomate American Board of Psychiatry and Neurology Certification in Neuropsychiatry and Behavioral Psychiatry Certification in Psychosomatic Medicine.